ŠČUREK, Martin, Šimon KLIMOVIČ, Martin PEŠL, Jan PŘIBYL, Daniil KABANOV, Deborah BECKEROVÁ, Markéta BÉBAROVÁ, Vladimír ROTREKL and Kristián BRAT. Effects of salbutamol and ipratropium on human stem-cells derived cardiomyocytes’ function. In ERS International Congress 2022. 2022. ISSN 0903-1936. Available from: https://dx.doi.org/10.1183/13993003.congress-2022.560.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Effects of salbutamol and ipratropium on human stem-cells derived cardiomyocytes’ function
Authors ŠČUREK, Martin (203 Czech Republic, belonging to the institution), Šimon KLIMOVIČ (203 Czech Republic, belonging to the institution), Martin PEŠL (203 Czech Republic, belonging to the institution), Jan PŘIBYL (203 Czech Republic, belonging to the institution), Daniil KABANOV (643 Russian Federation, belonging to the institution), Deborah BECKEROVÁ (203 Czech Republic, belonging to the institution), Markéta BÉBAROVÁ (203 Czech Republic, belonging to the institution), Vladimír ROTREKL (203 Czech Republic, belonging to the institution) and Kristián BRAT (703 Slovakia, belonging to the institution).
Edition ERS International Congress 2022, 2022.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30203 Respiratory systems
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 24.300
RIV identification code RIV/00216224:14110/22:00129720
Organization unit Faculty of Medicine
ISSN 0903-1936
Doi http://dx.doi.org/10.1183/13993003.congress-2022.560
Keywords in English human stem-cells derived cardiomyocytes’ function; salbutamol; ipratropium
Tags rivok
Tags International impact
Changed by Changed by: Mgr. Eva Dubská, učo 77638. Changed: 5/4/2024 22:34.
Abstract
Introduction: Patients with obstructive pulmonary diseases are treated by beta-2-agonists, parasympatholytics, and methylxanthines for long periods. Chronic use of these drugs may result in impairment of the cardiovascular system. Direct effects of these bronchodilators on the function of human cardiomyocytes are described insufficiently. Aims: We aimed to investigate in vitro effects of salbutamol and ipratropium on human-induced pluripotent stem cell-derived cardiomyocyte (hiPS-CMs) cell clusters. We focused on their chronotropic and inotropic effects. Methods: The measurements of 3D clusters of hiPS-CMs, embryoid bodies (EBs), with spontaneous pacing and contraction abilities were performed using atomic force microscopy (AFM). AFM enables real-time monitoring of EBs’ beating frequency and is capable of measuring its contractility. We measured the effect of increasing concentrations of salbutamol and ipratropium on EBs. Results: We treated 25 EBs with salbutamol and compared results with the control group of 11 EBs. Similarly, we tested 11 EBs with ipratropium. We observed significant positive chronotropic and inotropic effects in higher concentrations of salbutamol with statistically significant elevation of contraction force for clinically relevant salbutamol concentration. Measurements with ipratropium did not reveal any changes in EBs’ electromechanical function. Conclusions: The effect of pulmonary drugs on the cardiovascular system can be reliably tested using a combination of AFM and hiPS-CMs. The clinically relevant concentration of salbutamol causes a significant elevation of human cardiomyocytes’ contractility and beating frequency.
Links
LM2018127, research and development projectName: Česká infrastruktura pro integrativní strukturní biologii (Acronym: CIISB)
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/1328/2021, interní kód MUName: Stanovení hladin bronchodilatancií v plazmě a efekt jejich kombinací na buněčné kultury kardiomyocytů
Investor: Masaryk University
NU20-06-00156, research and development projectName: Vliv pneumologické medikace na funkce lidských kardiomyocytů.
Investor: Ministry of Health of the CR, Subprogram 1 - standard
PrintDisplayed: 22/7/2024 09:23